Jesper Johansen

Founder & Chief Executive Officer at Northstake

Jesper Johansen has extensive work experience in the life science and consulting industry. Jesper is currently the Founder and Chief Executive Officer of Northstake, a company they established in 2022. Prior to this, Jesper worked as a Senior Advisor at Biobridge Partners, specializing in life science strategy consulting. In this role, they provided guidance on operational and commercial strategies, R&D innovation, product launch planning, go-to-market strategies, and technology implementation projects. Jesper has served global and international life science and biopharma companies, focusing on various therapeutic areas such as metabolic diseases, chronic diseases, and skin diseases.

Before joining Biobridge Partners, Jesper worked at Accenture as the Nordic Life Science Strategy Lead from 2020 to 2022. Jesper also gained valuable experience at Deloitte, where they held positions as Manager and Senior Consultant between 2016 and 2020. Prior to that, they worked at NNIT as a Principal Consultant and Management Consultant from 2013 to 2016. Overall, Jesper Johansen's work experience demonstrates their expertise in strategic consulting and their ability to deliver effective solutions in the life science industry.

Jesper Johansen completed their Master of Business Administration (MBA) from Copenhagen Business School between 2015 and 2017. Prior to that, they obtained a Graduate Diploma in International Business (HD.IB, B.Sc.) from the same institution from 2010 to 2012. In 2008, Jesper Johansen received a Graduate Certificate in Business Administration (HD) from Copenhagen Business School.

Location

Copenhagen, Denmark

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices


Northstake

Northstake is your entry to institutional crypto stakingAt first glance, investing in crypto assets may appear daunting, complex and requiring technical, legal and financial knowhow. Getting exposure necessitates orchestrating multiple and fragmented services.Northstake changes that, giving institutional investors real exposure to regulatorycompliant staking products with Ethereum being the most important asset.​Our global client base commits us to help educate the future market participants.


Employees

11-50

Links